Literature DB >> 15914730

Better osteoporosis management a priority: impact predicted to soar with aging population.

Bridget M Kuehn.   

Abstract

Entities:  

Mesh：

Year:  2005        PMID： 15914730     DOI： 10.1001/jama.293.20.2453

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  8 in total

1.  The effect of moderate impact exercise on skeletal integrity in master athletes.

Authors:  N F Velez; A Zhang; B Stone; S Perera; M Miller; S L Greenspan
Journal:  Osteoporos Int       Date:  2008-03-20       Impact factor: 4.507

2.  Can bone quality be predicted accurately by Singh index in patients with rheumatoid arthritis?

Authors:  Cemal Bes; Melih Güven; Budak Akman; Evren Fehmi Atay; Emrah Ceviz; Mehmet Soy
Journal:  Clin Rheumatol       Date:  2011-06-08       Impact factor: 2.980

Review 3.  Safety considerations with bisphosphonates for the treatment of osteoporosis.

Authors:  William Strampel; Ronald Emkey; Roberto Civitelli
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

4.  Results of osteosynthesis with the ITST nail in fractures of the trochanteric region of the femur.

Authors:  Antonio Herrera; Javier Domingo; Angel Martinez
Journal:  Int Orthop       Date:  2007-07-06       Impact factor: 3.075

5.  Correlation of plain radiographic indices of the hip with quantitative bone mineral density.

Authors:  A P Sah; T S Thornhill; M S LeBoff; J Glowacki
Journal:  Osteoporos Int       Date:  2007-03-06       Impact factor: 4.507

6.  Gene co-expression network analysis identifies BRCC3 as a key regulator in osteogenic differentiation of osteoblasts through a β-catenin signaling dependent pathway.

Authors:  Lixiong Cai; Zhiqian Huo; Haiyun Yang; Fengchun He; Zhenglin Cao; Feng Wu; Lianjun Liu; Bingyin Sun
Journal:  Iran J Basic Med Sci       Date:  2019-02       Impact factor: 2.699

7.  Ibandronate: the first once-monthly oral bisphosphonate for treatment of postmenopausal osteoporosis.

Authors:  Frieder Bauss; Ralph C Schimmer
Journal:  Ther Clin Risk Manag       Date:  2006-03       Impact factor: 2.423

8.  Persistence with weekly and monthly bisphosphonates among postmenopausal women: analysis of a US pharmacy claims administrative database.

Authors:  Tao Fan; Qiaoyi Zhang; Shuvayu S Sen
Journal:  Clinicoecon Outcomes Res       Date:  2013-11-19
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.